Other Information
−Removed: During the three months ended December 31, 2024, none of our directors or officers entered into new or amended written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5 - 1 (c).
+Added: During the three months ended June 30, 2025 , none of our directors or officers entered into new or amended written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5 - 1 (c).
Description of Exhibit
Amended and Restated Articles of Incorporation of Mesa Laboratories, Inc.
−Removed: (incorporated by reference from exhibit 3.1 to the Current Report on Form 8-K filed August 25, 2023 (Commission File Number:
+Added: (incorporated by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed August 25, 2023).
Amended and Restated Bylaws of Mesa Laboratories, Inc.
−Removed: (incorporated by reference from exhibit 3.1 to the Current Report on Form 8-K filed on May 10, 2019 (Commission File Number:
+Added: (incorporated by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed May 10, 2019).
+Added: Form of 2026 Restricted Stock Unit Agreement, issued under the 2021 Equity Plan
+Added: Form of 2026 Performance Stock Unit Agreement, issued under the 2021 Equity Plan
+Added: Form of Amendment to Executive Employment Agreements, by and among Mesa Laboratories, Inc.
+Added: Owens, Sakys and Archbold
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
* Furnished herewith
+Added: α Mesa Laboratories, Inc.
+Added: has entered into an Executive Employment Agreement with each of Gary M.
+Added: Owens, John V.
+Added: Sakys and Brian Archbold.
+Added: ** Indicates a management contract or compensatory plan, contract or arrangement, or an amendment thereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MESA LABORATORIES, INC.
−Removed: February 4, 2025
+Added: August 5, 2025
Chief Executive Officer
−Removed: February 4, 2025
+Added: August 5, 2025
Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.